🇺🇸 FDA
Patent

US 12115225

GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof

granted A61KA61K31/7125A61K31/713

Quick answer

US patent 12115225 (GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof) held by Ionis Pharmaceuticals, Inc. expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/7125, A61K31/713, A61K38/1796, A61K47/549